Holly Quasny

7PUBLICATIONS
38CO-AUTHORS
Rheumatology and arthritisApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)OtorhinolaryngologyPsychosocial aspects of childbirth and perinatal mental healthMolecular medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Dec 11, 2024
Patients achieving low lupus disease activity state, systemic lupus erythematosus disease control or remission showed lower rates of organ damage during longitudinal follow-up: analysis of the Hopkins Lupus Cohort.

Jacob Hunnicutt, Mary Elizabeth Georgiou, Anna Richards

|Dec 23, 2023
Efficacy and safety of intravenous belimumab in a subgroup of South Korean patients with systemic lupus erythematosus enrolled into a Phase 3, randomized, placebo-controlled trial in North East Asia.

Chang-Hee Suh, Yoonhee Lee, Sang-Bae Yoo

|Apr 05, 2023
MOONLIGHT study: the design of a comparative study of the effectiveness of belimumab in patients with a history of lupus nephritis from the post-Marketed effectiveness of belimumab cOhOrt and JapaN Lupus NatIonwide reGistry (LUNA) coHorT.

Kenei Sada, Noriaki Kurita, Hisashi Noma

|Nov 30, 2022
Evaluating disease control following belimumab treatment in patients with SLE enrolled in the US OBSErve study.

Jacob N Hunnicutt, Jolyon Fairburn-Beech, Mary Elizabeth Georgiou

|Oct 05, 2022
Belimumab use during pregnancy: a summary of birth defects and pregnancy loss from belimumab clinical trials, a pregnancy registry and postmarketing reports.

Michelle Petri, Helain Landy, Megan E B Clowse

|Mar 29, 2022
Conceptual framework for defining disease modification in systemic lupus erythematosus: a call for formal criteria.

Ronald van Vollenhoven, Anca D Askanase, Andrew S Bomback

Pageof 2

Frequent Collaborators

3 joint publications

Roger A Levy

2 joint publications

Richard Furie

2 joint publications

Jacob N Hunnicutt

2 joint publications

Michelle Petri